04:36 PM EDT, 10/01/2025 (MT Newswires) -- Robert I Blum, Director, President & CEO, on October 01, 2025, sold 5,000 shares in Cytokinetics ( CYTK ) for $275,250. Following the Form 4 filing with the SEC, Blum has control over a total of 372,274 common shares of the company, with 368,108 shares held directly and 4,166 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198325000007/xslF345X05/form4.xml